Position in ANIP
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$15,971,987
-$187,010 QoQ
Shares Held
192,945
-8.2% QoQ
Ownership
0.840%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#38
of 303 holders
Holding Since
Mar 2022
13 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANIP Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Qube Research & Technologies Ltd holds $592,833,307 across 20 Drug Manufacturers - Specialty & Generic names. ANIP ranks #8 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
2,279,333 | $163,792,869 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
233,639 | $126,592,619 | |
| 3 | VTRS |
Viatris Inc
|
6,180,223 | $98,141,941 | |
| 4 | SUPN |
Supernus Pharmaceuticals, Inc.
|
922,166 | $42,889,940 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
2,207,432 | $35,385,134 | |
| 6 | XERS |
Xeris Biopharma Holdings, Inc.
|
2,893,749 | $22,918,492 | |
| 7 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
304,080 | $19,445,916 | |
| 8 | ANIP |
Ani Pharmaceuticals Inc
This page
|
192,945 | $15,971,987 |
All Filings in ANIP
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,971,987 | 192,945 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $16,158,997 | 210,130 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $17,199,526 | 217,881 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $17,422,411 | 190,201 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,971,071 | 76,185 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,390,382 | 35,704 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $3,312,377 | 59,920 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $4,516,560 | 75,705 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $9,997,441 | 156,995 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $8,124,572 | 117,526 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $5,747,517 | 104,235 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $3,007,217 | 51,795 | Shares | Sole | 2023-11-13 | |
| 2022-03-31 | $320,791 | 11,412 | Shares | Sole | 2022-05-09 | |
| No filing history on record for this holder in this stock. | ||||||